4/A//SEC Filing
RABBANI ELAZAR 4/A
Accession 0000930413-20-000592
CIK 0000316253other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:49 PM ET
Size
6.1 KB
Accession
0000930413-20-000592
Insider Transaction Report
Form 4/AAmended
RABBANI ELAZAR
DirectorChairman and CEO
Transactions
- Award
Stock Option (to acquire Common Stock)
2020-02-24+130,100→ 310,715 totalExercise: $2.20From: 2021-02-24Exp: 2025-02-24→ Common Stock (130,100 underlying)
Footnotes (2)
- [F1]The Reporting Person was granted 130,100 stock options. The stock options have a five-year term and will vest in two equal installments, one on the first anniversary of the grant date and the other on the second anniversary of the grant date.
- [F2]Does not include 31,700 Performance Stock Units granted to the Reporting Person on February 24, 2020, which will vest, if at all, based on (i) the achievement of certain average revenue growth and average adjusted EBITDA growth goals on February 24, 2023 and (ii) the continued employment of the Reporting Person through February 24, 2023.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeother
Related Parties
1- filerCIK 0000903568
Filing Metadata
- Form type
- 4/A
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:49 PM ET
- Size
- 6.1 KB